Jacobson Pharma Announces FY2023 Interim Results
HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, […]
Avance 临床赞助商在 2022 年 Informa Pharma Intelligence Awards 中获得年度生物技术公司奖
ADELAIDE, AUS, Aug 30, 2022 – (亚太商讯 via SEAPRWire.com) – Avance Clinical 是澳大利亚领先的国际生物技术 CRO，在 2022 年 Informa...
Avance Clinical进入Informa Pharma Intelligence 2022年亚太地区最佳CRO最终候选名单
ADELAIDE, AUS, Apr 19, 2022 – (亚太商讯 via SEAPRWire.com) – Avance Clinical是澳大利亚本地最大的CRO，致力于协助世界各地的生物科技及制药公司完成早...
Altamira Therapeutics 与 Nuance Pharma 优锐医药签署独家协议，在中国及部分亚洲市场共同开发和商业化Bentrio(TM) 鼻喷剂
Hamilton, Bermuda, Mar 4, 2022 – (亚太商讯 via SEAPRWire.com) – Altamira Therapeutics Ltd. (NASDAQ: CYTO) (简称“Al...
S’pore pharma firm pivots for pandemic success
You’re familiar with a key pandemic mantra: Wash your hands frequently with soap and water. No soap and water? Use hand sanitisers. Want to avoid alcohol-based sanitisers because of dry […]
Kintor Pharma Announces 2021 Interim Results
SUZHOU, CHINA, Aug 30, 2021 – (ACN Newswire via SEAPRWire.com) – Kintor Pharmaceutical Limited (“Kintor Pharma”, HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, today […]
Eisai to Divest Rights for Zonegran in Europe and Other Regions to Advanz Pharma
TOKYO, Jun 15, 2021 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for the antiepileptic agent […]
Making Strides in Covid-19 battle
Unlike its giant outsourcing companies such as Tata Consultancy Services and Infosys Technologies, India’s pharmaceutical makers are a lot less understated in their public profiles even as they are the […]
Jacobson Pharma’s Proposed Spin-off and Separate Listing of JBM (Healthcare) Limited on The Main Board of The Stock Exchange of Hong Kong Limited
HONG KONG, Jan 15, 2021 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, […]
Jacobson Pharma Announces FY2021 Interim Results
HONG KONG, Nov 27, 2020 – (ACN Newswire) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, […]
SinoMab Commenced Construction of its China Headquarters
HONG KONG, Nov 23, 2020 – (ACN Newswire) – SinoMab BioScience Limited (“SinoMab” or the “Company”, stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing […]